Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Chatain

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Cancers|August 27, 2021
The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR-ABL- and JAK2V617F-Positive MPNStefan Tillmann, Kathrin Olschok, Sarah K Schröder, et al.
British Journal of Haematology|June 30, 2025
ZIP10 as a potential therapeutic target in acute myeloid leukaemiaBenjamin Rolles, Nicolas Chatain, Richard Görg, et al.
Stem Cell Reports|October 22, 2021
CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytesKathrin Olschok, Lijuan Han, Marcelo A S de Toledo, et al.
Stem Cell Reports|January 26, 2024
Proinflammatory phenotype of iPS cell-derived JAK2 V617F megakaryocytes induces fibrosis in 3D in vitro bone marrow nicheNiclas Flosdorf, Janik Böhnke, Marcelo A S de Toledo, et al.
Frontiers in Oncology|March 15, 2021
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With <i>CALR</i>-Mutant Chronic Myeloproliferative NeoplasmsJacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Jørgensen, et al.
Blood Advances|January 28, 2025
Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alfaMilena Kalmer, Martin Grasshoff, Tiago Maié, et al.
Leukemia|November 25, 2018
JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activationJulia Czech, Sabrina Cordua, Barbora Weinbergerova, et al.
Blood|May 23, 2018
Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitorsSilvia Maifrede, Margaret Nieborowska-Skorska, Katherine Sullivan-Reed, et al.
Blood|January 29, 2021
Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosisMarcelo A S Toledo, Malrun Gatz, Stephanie Sontag, et al.
Cell Reports|December 20, 2023
Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasmsJessica E Pritchard, Juliette E Pearce, Inge A M Snoeren, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Cancers|August 27, 2021
The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR-ABL- and JAK2V617F-Positive MPNStefan Tillmann, Kathrin Olschok, Sarah K Schröder, et al.
British Journal of Haematology|June 30, 2025
ZIP10 as a potential therapeutic target in acute myeloid leukaemiaBenjamin Rolles, Nicolas Chatain, Richard Görg, et al.
Stem Cell Reports|October 22, 2021
CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytesKathrin Olschok, Lijuan Han, Marcelo A S de Toledo, et al.
Stem Cell Reports|January 26, 2024
Proinflammatory phenotype of iPS cell-derived JAK2 V617F megakaryocytes induces fibrosis in 3D in vitro bone marrow nicheNiclas Flosdorf, Janik Böhnke, Marcelo A S de Toledo, et al.
Frontiers in Oncology|March 15, 2021
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With <i>CALR</i>-Mutant Chronic Myeloproliferative NeoplasmsJacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Jørgensen, et al.
Blood Advances|January 28, 2025
Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alfaMilena Kalmer, Martin Grasshoff, Tiago Maié, et al.
Leukemia|November 25, 2018
JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activationJulia Czech, Sabrina Cordua, Barbora Weinbergerova, et al.
Blood|May 23, 2018
Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitorsSilvia Maifrede, Margaret Nieborowska-Skorska, Katherine Sullivan-Reed, et al.
Blood|January 29, 2021
Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosisMarcelo A S Toledo, Malrun Gatz, Stephanie Sontag, et al.
Cell Reports|December 20, 2023
Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasmsJessica E Pritchard, Juliette E Pearce, Inge A M Snoeren, et al.
Pageof 5